Medical Condition News

RSS

OSU biophysicist leverages computer cluster to develop drug to block small protein molecule IL-6

An Ohio State biophysicist used a supercomputer to search thousands of molecular combinations for the best configuration to block a protein that can cause breast or prostate cancer.

20 Apr 2011

Biomerix receives Health Canada licenses for REVIVE and ASSURE Hernia Repair Meshes

Biomerix Corporation announced today it has received two Class III Medical Device Licenses by Health Canada for its REVIVE and ASSURE Hernia Repair Meshes.

20 Apr 2011

Product name impacts dieters' food evaluations

Dieters are so involved with trying to eat virtuously that they are more likely than non-dieters to choose unhealthy foods that are labeled as healthy, according to a new study in the Journal of Consumer Research. It seems dieter focus on food names can work to their disadvantage.

20 Apr 2011

Medically vulnerable families can benefit from high-deductible health plans

People who are medically vulnerable -- those with low incomes or chronic health problems -- who enroll in high-deductible health plans are at no more risk for cutting back on needed health care than other people who enroll in the plans, according to a new RAND Corporation study.

20 Apr 2011

Treatment commences in NeuroVive-HCL's 1,000 patient European cardioprotection trial

NeuroVive Pharmaceutical and Hospices Civils de Lyon (HCL) today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction (the CIRCUS study). NeuroVive's advanced CicloMulsion(TM) cremophor-free IV cyclosporine formulation is used in this study of 1,000 patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction to examine cyclosporine's ability to protect cardiac tissue.

20 Apr 2011

Dogs develop cancer that is biologically similar to a human tumour

Despite steadily improving methods for its diagnosis and treatment, cancer still represents one of the most frequent causes of death in humans. What is less well known is that this also holds true for pets such as dogs.

20 Apr 2011

A cluttered brain doesn't remember

Lapses in memory occur more frequently with age, yet the reasons for this increasing forgetfulness have not always been clear. According to new research from Concordia University, older individuals have reduced learning and memory because their minds tend to be cluttered with irrelevant information when performing tasks.

20 Apr 2011

FDA approves Rituxan-corticosteroid combination for Wegener's Granulomatosis and Microscopic Polyangiitis

Genentech, a member of the Roche Group and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab), in combination with corticosteroids, as a new medicine for adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA).

20 Apr 2011

Alzheimer’s diagnostic guidelines released

Neurologists and experts have come up with a set of guidelines to better diagnose Alzheimer's disease in the clinic for the first time in nearly three decades. The advice also helps doctors identify the earliest signs of the degenerative condition, even before symptoms of memory loss begin. The hope is that they can help patients prepare early, and eventually treat, the disease.

19 Apr 2011

New guidelines allow definition of pre-Alzheimer's

The emphasis on the need to diagnose Alzeheimer's during its earliest stages is also evident in Congress, where legislation introduced this month would create new, specific Medicare cost codes for early-disease diagnosis to address these steps, including the discussions between the physician and caregivers.

19 Apr 2011

EMA CHMP grants positive opinion for Biogen Idec's AVONEX PEN

Biogen Idec announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of AVONEX® PEN™ for patients with relapsing multiple sclerosis (MS) and patients with a single demyelinating event.

19 Apr 2011

NeuroVive, HCL initiate CicloMulsion Phase III trial in myocardial infarction

NeuroVive Pharmaceutical and Hospices Civils de Lyon today announced the enrollment and treatment of the first patient in the European multicenter trial of myocardial infarction.

19 Apr 2011

Gene mutation in Tibetian Terrier dogs causes hereditary form of Parkinson's disease in humans

University of Missouri researchers believe both man and animal will benefit from their discovery that the same gene mutation found in Tibetan Terrier dogs can also be found in a fatal human neurological disorder related to Parkinson's disease.

19 Apr 2011

RaySearch receives order for its RayStation system from RISO

RaySearch Laboratories AB has received an order for its RayStation treatment planning system from RISO, the Radiotherapeutic Institute in Deventer, the Netherlands.

19 Apr 2011

Pupil measurements can predict patients' response to cognitive therapy

The scientific foundation of psychiatry is growing rapidly, yet it is a branch of medicine distinctive for the relative absence of biological tests in routine clinical practice.

19 Apr 2011

SafeMinds calls for immediate vaccine safety studies in autistic children

Alison MacNeil issued the following statements today regarding vaccines.

19 Apr 2011

Cumberland acquires Vanderbilt's ifetroban rights

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it has entered into an agreement to acquire the rights to ifetroban, a new Phase II development product.

19 Apr 2011

Radiology publishes Riverain Medical's SoftView chest X-ray study data in lung cancer

Riverain Medical, an industry leader and innovator in computer-aided detection and advanced visualization technologies, today announced the publication of a peer-reviewed study in Radiology demonstrating that radiologists using Riverain Medical's SoftView bone suppression application with chest X-rays significantly increased their detection of lung nodules proven to be primary lung cancer.

19 Apr 2011

Positive interim anemia response data from YM's CYT387 Phase I/II trial in myelofibrosis

YM BioSciences Inc., today announced that updated interim anemia response data were reported for the first 60 patients enrolled in the Phase I/II trial of its JAK1/JAK2 inhibitor, CYT387, for the treatment of myelofibrosis.

19 Apr 2011

Obese patients may face high risk of complications after non-cardiac surgery

Obese patients with high blood pressure and diabetes are at much higher risk for major complications following non-cardiac surgery compared to otherwise healthy obese patients and patients of normal weight.

19 Apr 2011

Medical Condition News

OSU biophysicist leverages computer cluster to develop drug to block small protein molecule IL-6

Biomerix receives Health Canada licenses for REVIVE and ASSURE Hernia Repair Meshes

Product name impacts dieters' food evaluations

Medically vulnerable families can benefit from high-deductible health plans

Treatment commences in NeuroVive-HCL's 1,000 patient European cardioprotection trial

Dogs develop cancer that is biologically similar to a human tumour

A cluttered brain doesn't remember

FDA approves Rituxan-corticosteroid combination for Wegener's Granulomatosis and Microscopic Polyangiitis

Alzheimer’s diagnostic guidelines released

New guidelines allow definition of pre-Alzheimer's

EMA CHMP grants positive opinion for Biogen Idec's AVONEX PEN

NeuroVive, HCL initiate CicloMulsion Phase III trial in myocardial infarction

Gene mutation in Tibetian Terrier dogs causes hereditary form of Parkinson's disease in humans

RaySearch receives order for its RayStation system from RISO

Pupil measurements can predict patients' response to cognitive therapy

SafeMinds calls for immediate vaccine safety studies in autistic children

Cumberland acquires Vanderbilt's ifetroban rights

Radiology publishes Riverain Medical's SoftView chest X-ray study data in lung cancer

Positive interim anemia response data from YM's CYT387 Phase I/II trial in myelofibrosis

Obese patients may face high risk of complications after non-cardiac surgery

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News